n-3 Polyunsaturated fatty acids for the prevention of postoperative atrial fibrillation (original) (raw)

Preoperative n-3 Polyunsatured Fatty Acids Are Associated With a Decrease in the Incidence of Early Atrial Fibrillation Following Cardiac Surgery

Maciej Banach

Angiology, 2010

View PDFchevron_right

A Small Cohort Omega-3 PUFA Supplement Study: Implications of Stratifying According to Lipid Membrane Incorporation in Cardiac Surgical Patients

Julian Smith

Heart, lung & circulation, 2017

View PDFchevron_right

The ω-3 fatty acids for Prevention of Post-Operative Atrial Fibrillation trial—rationale and design

Richard S Page

American Heart Journal, 2011

View PDFchevron_right

Plasma n-3 and n-6 fatty acids and the incidence of atrial fibrillation following coronary artery bypass graft surgery

G. Skuladottir

European Journal of Clinical Investigation, 2011

View PDFchevron_right

Do High Levels of n-3 Polyunsaturated Fatty Acids in Cell Membranes Increase the Risk of Postoperative Atrial Fibrillation?

Kristin Skogstrand

Cardiology, 2013

View PDFchevron_right

N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery

Filippo Lamberti

View PDFchevron_right

A Randomized, Placebo-Controlled Trial of Omega-3 Fatty Acids for Inhibition of Supraventricular Arrhythmias After Cardiac Surgery: The FISH Trial

Helge Refsum

Journal of the American Heart Association, 2012

View PDFchevron_right

N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials

Sergio Varini

Journal of the American Heart Association, 2013

View PDFchevron_right

Antioxidant supplementations for prevention of atrial fibrillation after cardiac surgery: an updated comprehensive systematic review and meta-analysis of 23 randomized controlled trials

hamid reza dehghan manshadi

Interactive CardioVascular and Thoracic Surgery, 2014

View PDFchevron_right

EXPERIMENTAL & CLINICAL CARDIOLOGY Title: "Oral Administration of N-3 Long-chain Fatty Acids Reduce Inflammatory Response and Improve Clinical Outcomes in Patients with Cardiovascular Surgery" How to reference: Oral Administration of N-3 Long-chain Fatty Acids Reduce Inflammatory Response and Imp...

Jorge Maldonado

Experimental and clinical cardiology

View PDFchevron_right

N-3 polyunsaturated fatty acids reduces post-operative atrial fibrillation incidence in patients undergoing "on-pump" coronary artery bypass graft surgery

Francesco Tritto, Mario Sorice

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo, 2011

View PDFchevron_right

Prevention of postoperative atrial fibrillation: Lukewarm progress

giovanni de gaetano

Critical Care Medicine, 2000

View PDFchevron_right

Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial

Annette West

Circulation. Arrhythmia and electrophysiology, 2010

View PDFchevron_right

U-shaped relationship between tissue docosahexaenoic acid and atrial fibrillation following cardiac surgery

G. Skuladottir

European Journal of Clinical Nutrition, 2014

View PDFchevron_right

Prophylactic Antioxidant use for the Prevention of Post-Operative Atrial Fibrillation in Cardiac Surgery Patients

Ross Davis

2014

View PDFchevron_right

About the controversies of the cardioprotective effect of n-3 polyunsaturated fatty acids (PUFAs) between animal studies and clinical meta-analyses: a review with several strategies to enhance the beneficial effects of n-3 PUFAs

Luc Demaison

Journal of Physiology and Biochemistry, 2019

View PDFchevron_right

Omega-3 Fatty Acid Supplementation Does Not Reduce Risk of Atrial Fibrillation After Coronary Artery Bypass SurgeryCLINICAL PERSPECTIVE

palaniappan saravanan

Circulation: …, 2010

View PDFchevron_right

Rationale and design of a randomised controlled clinical trial on supplemental intake of n-3 fatty acids and incidence of cardiac arrhythmia: SOFA

P. Zock

European Journal of Clinical Nutrition, 2003

View PDFchevron_right

Omega-3 PUFAs and Atrial Fibrillation: Have We Made Up Our Mind Yet?

Federico Guerra

Annals of Noninvasive Electrocardiology, 2013

View PDFchevron_right

N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study

Senol Tayyar, Bayram Uysal

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, 2011

View PDFchevron_right

n-3 PUFAs and cardiovascular disease prevention

Enrico Vizzardi

Future Cardiology, 2010

View PDFchevron_right

n-3 Polyunsaturated Fatty Acids After Coronary Artery Bypass Grafting

Giovanni Melina

The Annals of Thoracic Surgery, 2011

View PDFchevron_right

Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial

Roberto Latini

Journal of the American Heart Association, 2013

View PDFchevron_right

Perspectives on n-3 PUFAs: primary prevention, antiarrhythmic effects, congestive heart failure

Fausto Avanzini

European Heart Journal Supplements, 2001

View PDFchevron_right

Clinical outcome and atherothrombogenic risk profile after prolonged wash-out following long-term treatment with high doses of n-3 PUFAs in patients with an acute myocardial infarction

Dennis Nilsen

Clinical Nutrition, 2004

View PDFchevron_right